Supplementary Table 2. Correlations between the proinflammatory/anti-inflammatory phenotypes of circulating monocytes or carotid plaque and the duration of diabetes in diabetic patients (n = 12).
| Duration of diabetes |
||
|---|---|---|
| ρ | P-value | |
| mRNA level in monocytes | ||
| TNF-α | −0.279 | 0.407 |
| IL-6 | −0.060 | 0.854 |
| IL-10 | −0.046 | 0.894 |
| CD14 | −0.298 | 0.346 |
| CD16 | 0.144 | 0.656 |
| CD68 | −0.025 | 0.940 |
| mRNA level in plaque | ||
| TNF-α | −0.324 | 0.331 |
| IL-6 | −0.249 | 0.435 |
| IL-10 | 0.208 | 0.516 |
| MHC-II | −0.225 | 0.483 |
| CD86 | 0.242 | 0.448 |
| CD206 | −0.474 | 0.120 |
| Dectin-1 | 0.021 | 0.948 |
| Percent of positive cells in plaque | ||
| TNF-α | 0.126 | 0.696 |
| IL-6 | 0.175 | 0.585 |
| IL-10 | −0.488 | 0.108 |
| MHC-II | −0.228 | 0.476 |
| CD86 | 0.042 | 0.897 |
| CD206 | 0.119 | 0.712 |
| CD3 | 0.151 | 0.640 |
ρ, Spearman's rank correlation coefficient